Davion Healthcare Plc. (NASDAQ:DAVI – Get Free Report) was the recipient of a large growth in short interest in October. As of October 30th, there was short interest totaling 617,708 shares. Based on an average daily trading volume, of 1,928,918 shares, the days-to-cover ratio is presently 0.3 days. Currently, 2.5% of the company’s stock are sold short.
Davion Healthcare Stock Performance
NASDAQ DAVI traded up $0.05 on Monday, hitting $1.05. 271,044 shares of the company were exchanged, compared to its average volume of 1,424,865. Davion Healthcare has a twelve month low of $0.91 and a twelve month high of $12.30.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded Davion Healthcare to a “hold” rating in a research report on Saturday, October 31st.
Read Our Latest Report on Davion Healthcare
About Davion Healthcare
Davion Healthcare Plc is a digital healthcare company developing proprietary, non-invasive health monitoring technologies designed to support the early identification of medical anomalies outside traditional clinical environments. The Company’s flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. Davion Healthcare Plc is based in DUBLIN.
Featured Articles
- Five stocks we like better than Davion Healthcare
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
- 3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?
Receive News & Ratings for Davion Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davion Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
